Form 4 for CAI Caris Life Sciences, Inc.
Accepted 2025-08-13 00:00:00 ET · period of report 2025-08-11 · accession 0001104659-25-077777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-13 | 2025-08-11 | CAI | POSTE GEORGE | Dir | F - Tax | $29.75 | -139.5K | 311.7K | -31% | -$4.15M |
| D | 2025-08-13 | 2025-08-11 | CAI | POSTE GEORGE | Dir | M - OptEx | $2.44 | +125.0K | 359.8K | +53% | +$305.0K |
| D | 2025-08-13 | 2025-08-11 | CAI | POSTE GEORGE | Dir | M - OptEx | $0.00 | +125.0K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-11 | F | D | 91,495 | $29.75 | 220,237 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-11 | F | D | 48,022 | $29.75 | 311,732 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-11 | M | A | 125,000 | $2.44 | 359,754 | D | — | — | |
| 4 | Derivative | Stock Option | 2025-08-11 | M | A | 125,000 | $0.00 | 0 | D | $2.44 · — to 2025-09-15 | 125,000 Common Stock | (F1) The stock option is fully vested and exercisable. |